Smartfish AS has initiated a strategic collaboration with the global healthcare company B. Braun to secure a global launch of its medical nutrition product Remune.
B. Braun will launch Remune in close to 20 countries during 2019 and 2020, followed by several other markets in Europe, Asia and South America. The collaboration also opens up for potential future launches by B. Braun of other innovative products based on Smartfish’s technology, states the company.
“Smartfish is a research-focused life science company and finding the right distributors to efficiently reach the global market is a crucial part of our business model. The collaboration with B. Braun is the result of a thorough process and marks the beginning of a global launch of our products,” says Geir Harstad, CEO of Smartfish.
Effects in clinical trials in cancer and COPD patients
Smartfish provides nutrition products with high levels of Omega 3 fatty acids, and its medical nutrition products are used to improve the nutritional status of malnourished or undernourished patients and has shown statistically significant effects in clinical trials in cancer and COPD patients. Recently published data from a double-blinded, placebo-controlled pilot study indicate that Remune can improve overall survival in undernourished patients with non-small-cell lung cancer.
Photo of Geir Harstad, CEO, Smartfish